The focus of pharma on cancer drug development makes cancer trials the most prevalent across therapeutic areas. However they are also some of the most complex, time consuming and expensive trials and slow down the speed to market for new cancer drugs.
Recruiting patients, monitoring sites and analysing complex data can be daunting for cost-sensitive pharma’s, which is why more and more turn to CROs with oncology expertise to help tap the lucrative cancer therapeutics market
The Oncology Trials Outsourcing will look at the role of external partnerships in achieving success in oncology trials, an example of how pharma have successfully worked with CRO’s to commercialise a new cancer therapy and examine strategies for successfully recruiting patients to oncology trials.
Denise Calaprice, Ph.D
Client Relationship Management
The Avoca Group
Sourcing consultant & relationship manager - Oncology
Sponsored by Novotech
clinical program leader, oncology, global clinical operations
Johnson & Johnson
On the day of the event, navigate to the exhibition hall. In there, you will be able to communicate LIVE with industry experts through a range of networking tools:
Oncology Trials Outsourcing 2012 extends the reach of a
traditional conference or trade show.
It is just like a physical conference or a show, but without leaving your desk!
Oncology Trials Outsourcing 2012 targets Research and Development Managers, Project Managers, Clinical Trials Managers, Regulatory Affairs/Compliance Managers and Clinical Research Coordinators. All are involved in pharmaceutical/biopharmaceutical companies, contract research organizations and clinical laboratories bringing new cancer treatment drugs to the market.